Rise and shine. Another busy day is on the way. As usual, we are scurrying about here on the Pharmalot corporate campus, where the early morning frost is dissipating, the officials mascots are fertilzing the weeds and the mandatory cup of stimulation is brewing on the stove. No time to dilly dally, of course, so here are some tidbits to get you started. Hope your day goes well and drop us a line if you come across anything interesting...
Amylin Spurned $3.5B Offer From Bristol-Myers Squibb (Bloomberg News)
Veterinarians Frustrated By Novartis Backorders (VIN News)
Chelsea Therapeutics Awaits FDA Decision On Key Drug (Med City News)
Pfizer Stock Rises After Analyst Reports Suggests A Break Up (Bloomberg News)
Three Indian Drugmakers Rush To Launch Generic Seroquel (Dow Jones)
Judge Bars Import Of Drug Used For Death Penalty (Reuters)
Japanese Companies Launch Biosimilar Joint Venture (Pharma Times)
FDA Targets Cosmeceuticals Straddling Regulatory Lines (Bloomberg News)
Targacept Ends Development Of Diabetes Drug (Dow Jones)
India Finds 1,420 Substandard Drug Samples (InPharma Technologist)
EDITOR'S NOTE: Please check this post for updates throughout the morning
steaming coffee thx to dleggett on flickr
2 Comments
I read the article on Pfizer's stock rising. I don't believe ANYthing Pfizer says. They're saying that so their stockholders will continue to "hang" w/them. Eventually, the truth will come out. With all the scandal and lawsuits facing Pfizer right now...they're going to NEED to have alot of money.
Pfizer's pipeline is drying up. PREDICTION: Pfizer's doors w/close in the next 10 years. It's been a good run for them. Their lies and employee abuse w/catch up w/them soon.
Terri - Wish I could agree that "their lies....w/catch up w/them soon"...but it seems that, with pharma, anything goes. At least that's how the feds see it. With crystal clear evidence of malfeasance that has caused countless deaths from side effects and purposeful hiding of negative clinical trial evidence, obfuscation, off-label marketing, and so forth, not ONE pharmaceutical executive has been indicted for anything.